The custom antibody market in Middle East and Africa is expected to grow from US$ 14.0 million in 2021 to US$ 25.0 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028.
Antibodies, including monoclonal and polyclonal, find applications in academic, research, and pharmaceutical institutes and organizations. Using these antibodies, institutes and organizations conduct several research and development activities for drug and biomarker developments, and other therapeutic and clinical diagnostics product developments. Custom antibodies are widely preferred in research to differentiate the antibody products. These antibodies are continuously evaluated to provide safe, accurate, and efficient products with improved quality. Small and medium-sized companies have increased their research and development investments and activities exponentially. Such investments have escalated the demand for custom antibodies.The pandemic has affected the research and development activities in these countries. Apart from this, a considerable population already faces a growing burden of non-communicable diseases, making them more vulnerable to the virus. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and have been unable to implement any public health measures. In addition, Iran was in a deep economic recession due to the US sanctions. These factors are expected to impact the growth of the market in the region negatively. In addition, the primary source of economic stabilization in Middle East countries is oil production and export. However, the current pandemic is creating turbulence in the economics of the Middle East region. An immediate drop in domestic and external demand for goods and products, primarily crude oil, and halted production due to labor deficiency are significant impacts observed in the region. Additionally, tightened financial condition is also decreasing the overall economic activities in the area. This uncertainty with average delays often associated with regulatory approvals in low- and middle-income countries is hindering the market's growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the custom antibody market. The Middle East and Africa Custom antibody market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Middle East and Africa Custom Antibody Market Segmentation
By Service
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Custom Antibodies
By Source
- Mice
- Rabbits
- Others
By Research Area
- Oncology
- Immunology
- Stem Cells
- Infectious Diseases
- Neurobiology
- Cardiovascular Diseases
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Country
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Agilent Technologies, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Service, Type, Source, Research Area, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Saudi Arabia
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Custom Antibody Market – By Service
1.3.2 Custom Antibody Market – By Type
1.3.3 Custom Antibody Market – By Source
1.3.4 Custom Antibody Market – By Research Area
1.3.5 Custom Antibody Market – By End User
1.3.6 Middle East and Africa Custom Antibody Market – By Country
2. Middle East and Africa Custom Antibody Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Custom Antibody Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Custom Antibody Market- Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Custom Antibody Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Demand in Research
5.1.2 Market Consolidations Strategies Adopted by Biotechnology Companies
5.1.3 Production and Development Services Offered by Custom Antibody Providers
5.2 Market Restraints
5.2.1 High Cost of Production
5.3 Market Opportunities
5.3.1 Proliferation of Biotechnology Industry in Developing Regions
5.4 Future Trends
5.4.1 Developments for Custom Antibodies
5.5 Impact Analysis
6. Custom Antibody Market – Middle East and Africa Analysis
6.1 Middle East and Africa Custom Antibody Market Revenue Forecasts and Analysis
7. Middle East and Africa Custom Antibody Market Analysis and Forecasts To 2028 – By Service
7.1 Overview
7.2 Custom Antibody Market Revenue Share, by Service (2020 and 2028)
7.3 Antibody Development
7.3.1 Overview
7.3.2 Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Antibody Production and Purification
7.4.1 Overview
7.4.2 Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Antibody Fragmentation and Labelling
7.5.1 Overview
7.5.2 Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8. Middle East and Africa Custom Antibody Market Analysis and Forecasts To 2028 – By Type
8.1 Overview
8.2 Custom Antibody Market Revenue Share, by Type (2020 and 2028)
8.3 Monoclonal Antibodies
8.3.1 Overview
8.3.2 Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Polyclonal Antibodies
8.4.1 Overview
8.4.2 Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Other Custom Antibodies
8.5.1 Overview
8.5.2 Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
9. Middle East and Africa Custom Antibody Market Analysis and Forecasts To 2028 – By Source
9.1 Overview
9.2 Custom Antibody Market Revenue Share, By Source (2020 and 2028)
9.3 Mice
9.3.1 Overview
9.3.2 Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Rabbit
9.4.1 Overview
9.4.2 Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East and Africa Custom Antibody Market Analysis and Forecasts to 2028– By Research Area
10.1 Overview
10.2 Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Immunology
10.4.1 Overview
10.4.2 Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Stem Cells
10.5.1 Overview
10.5.2 Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Infectious Disease
10.6.1 Overview
10.6.2 Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Neurobiology
10.7.1 Overview
10.7.2 Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Cardiovascular Disease
10.8.1 Overview
10.8.2 Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
11. Middle East and Africa Custom Antibody Market Analysis and Forecasts to 2028– By End User
11.1 Overview
11.2 Custom Antibody Market Revenue Share, by End User (2020 and 2028)
11.3 Pharmaceutical and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
11.4 Academic and Research Institutes
11.4.1 Overview
11.4.2 Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
11.5 Contract Research Organizations
11.5.1 Overview
11.5.2 Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
12. Custom Antibody Market Revenue and Forecasts to 2028 – Geographical Analysis
12.1 Middle East & Africa: Custom Antibody Market Revenue and Forecasts To 2028
12.1.1 Overview
12.1.2 Middle East and Africa: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.1.2.1 Saudi Arabia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 Saudi Arabia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 Saudi Arabia: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.1.3 Saudi Arabia: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.1.4 Saudi Arabia: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.1.5 Saudi Arabia: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.1.2.1.6 Saudi Arabia: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.2 UAE: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 UAE: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 UAE: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.2.3 UAE: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.2.4 UAE: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.2.5 UAE: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.1.2.2.6 UAE: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.3 South Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 South Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 South Africa: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.3.3 South Africa: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.3.4 South Africa: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.3.5 South Africa: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.1.2.3.6 South Africa: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.4 Rest of Middle East and Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 Rest of Middle East and Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.2 Rest of Middle East and Africa: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.4.3 Rest of Middle East and Africa: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.4.4 Rest of Middle East and Africa: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.4.5 Rest of Middle East and Africa: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.1.2.4.6 Rest of Middle East and Africa: Custom Antibody Market, by End User, 2019–2028 (USD Million)
13. Impact Of COVID-19 Pandemic on Middle East and Africa Custom Antibody Market
13.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
14. Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. COMPANY PROFILES
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 BIO-RAD LABORATORIES INC.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 MERCK KGaA
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 ABCAM
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 GenScript
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Agilent Technologies, Inc.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
16. Appendix
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East and Africa Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East and Africa Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East and Africa Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East and Africa Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East and Africa Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Recent Inorganic Growth Strategies in the Custom Antibody Market
Table 22. Recent Organic Growth Strategies in the Custom Antibody Market
Table 23. Glossary of Terms, Custom Antibody Market
LIST OF FIGURES
Figure 1. Custom Antibody Market Segmentation
Figure 2. Middle East and Africa Custom Antibody Market Overview
Figure 3. Antibody Development Segment Held Largest Share of Service in Custom Antibody Market
Figure 4. UAE is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Custom Antibody Market - Middle East and Africa PEST Analysis
Figure 6. Custom Antibody Market Impact Analysis of Driver and Restraints
Figure 7. Middle East and Africa Custom Antibody Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Custom Antibody Market Revenue Share, by Service (2020 and 2028)
Figure 9. Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Custom Antibody Market Revenue Share, by Type (2020 and 2028)
Figure 13. Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Custom Antibody Market Revenue Share, by Source (2020 and 2028)
Figure 17. Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
Figure 21. Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Custom Antibody Market Revenue Share, by End User (2020 and 2028)
Figure 29. Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Middle East and Africa: Custom Antibody Market, by Key Country – Revenue (2020) (USD Million)
Figure 33. Middle East and Africa: Custom Antibody Market, by Country, 2020 & 2028 (%)
Figure 34. Saudi Arabia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. UAE: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. South Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Rest of Middle East and Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 39. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Agilent Technologies, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Middle East and Africa Custom Antibody Market
Jul 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jul 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jul 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)